Business Context and Reporting Period
This Form 8-K is filed by Integrated Security Technologies, Inc. (not Oramed Pharmaceuticals Inc., as noted in the metadata) on July 14, 2004. The report discloses a change in the company's certifying accountant and a change in its fiscal year end. The company is incorporated in Nevada and operates from New York, New York.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. The text notes that the company was in the "exploration stage" during the periods audited by the former accountant. The most recent fiscal year ended June 30, 2004, has not yet been audited.
Material Changes
- Change in Accountant: Effective July 14, 2004, the company dismissed Morgan & Company, Chartered Accountants, and engaged Malone & Bailey, PLLC as its new principal independent public accountant.
- Fiscal Year Change: The Board of Directors approved changing the fiscal year end from August 31 to June 30.
- Audit History: The former accountant (Morgan) audited financial statements for periods ending August 31, 2002, and August 31, 2003. Their reports included a concern regarding the company's ability to continue as a going concern but contained no adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
Outlook, Risks, and Contingencies
There were no disagreements between the company and the former accountant regarding accounting principles, financial statement disclosure, or auditing scope. No reportable events occurred during the relevant periods. The company has authorized the former accountant to respond to inquiries from the new auditor. The new accountant (Malone) has reviewed the disclosure and did not provide a letter of disagreement to the Commission.
Investor Verification Checklist
- Verify the upcoming Form 10-KSB filing for the fiscal year ended June 30, 2004, to assess the company's financial status post-fiscal year change.
- Review the "going concern" qualification noted in prior audits to understand the company's liquidity risks.
- Confirm the transition of audit responsibilities between Morgan & Company and Malone & Bailey, PLLC.
- Note the discrepancy between the metadata company name (Oramed Pharmaceuticals Inc.) and the filing registrant (Integrated Security Technologies, Inc.).